MRSN – mersana therapeutics, inc. (US:NASDAQ)
Stock Stats
News
12/3
04:32 pm
mrsn
Low
Mersana Therapeutics (NASDAQ:MRSN) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
11/30
05:30 am
mrsn
Low
How Mersana's Acquisition Is Changing the Story and Analyst Outlook for Investors [Yahoo! Finance]
11/16
07:04 pm
mrsn
Low
Mersana Therapeutics Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Mersana Therapeutics, Inc. - MRSN
11/15
07:05 pm
mrsn
Low
How the Acquisition Is Reshaping Mersana Therapeutics' Story and Analyst Outlook [Yahoo! Finance]
11/15
10:33 am
mrsn
Low
Mersana Therapeutics (NASDAQ:MRSN) was downgraded by analysts at Leerink Partnrs from a "strong-buy" rating to a "hold" rating.
11/14/2025
07:00 am
MRSN
2.6%
MISS
8/13/2025
07:00 am
MRSN
13.7%
MISS
5/15/2025
07:00 am
MRSN
-19.5%
BEAT
3/3/2025
07:01 am
MRSN
-4.5%
BEAT
11/14
09:42 am
Reiterates
Buy
Neutral
Guggenheim
Low
2.5%
11/14
09:42 am
Reiterates
Buy
Neutral
Guggenheim
Low
2.5%
11/14
09:08 am
Downgrades
Buy
Neutral
Guggenheim
Low
2.4%
11/14
09:08 am
Downgrades
Buy
Neutral
Guggenheim
Low
2.4%
11/14
07:52 am
Downgrades
Strong-Buy
Hold
Wedbush
Low
2.6%
12/5
04:24 pm
mrsn
Low
Form SC 14D9 Mersana Therapeutics, Filed by: Mersana Therapeutics, Inc.
12/5
04:02 pm
mrsn
Low
Form SC TO-T Mersana Therapeutics, Filed by: Day One Biopharmaceuticals, Inc.
12/4
04:06 pm
mrsn
Low
Form SC TO-C Mersana Therapeutics, Filed by: Day One Biopharmaceuticals, Inc.
11/24
05:13 pm
mrsn
Low
Form SCHEDULE 13G Mersana Therapeutics, Filed by: 683 Capital Management, LLC
11/14
04:20 pm
mrsn
Low
Form SCHEDULE 13G Mersana Therapeutics, Filed by: Schonfeld Strategic Advisors LLC
Show more
Top News Gainers
4/8 Mersana Therapeutics secures $65M capital raise [Seeking Alpha] 33.5%
1/16 Mersana Therapeutics Inc (NASDAQ: MRSN) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 22.7%
2/8 Mersana Therapeutics Inc (NASDAQ: MRSN) was upgraded by analysts at ValuEngine from a "sell" rating to a "hold" rating. 14.9%
11/27 Form 8-K Mersana Therapeutics, For: Nov 26 12.6%
2/28 Mersana Therapeutics, Inc. (MRSN) CEO Anna Protopapas on Q4 2019 Results - Earnings Call Transcript [Seeking Alpha] 10.7%
2/18 Mersana Therapeutics to Present at Upcoming Investor Conferences 9.1%
12/23 Form SC 13G Mersana Therapeutics, Filed by: Venrock Healthcare Capital Partners II, L.P. 9.1%
5/9 Form 10-Q Mersana Therapeutics, For: Mar 31 8.3%
10/10 Mersana Therapeutics Inc (NASDAQ: MRSN) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. 8.1%
11/6 Form 8-K Mersana Therapeutics, For: Nov 06 7.0%
Top News Decliners
3/30 Form 8-K Mersana Therapeutics, For: Mar 30 -15.5%
3/14 Mersana Therapeutics Inc (NASDAQ: MRSN) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $6.50 price target on the stock. -13.8%
12/28 Mersana Therapeutics Inc (NASDAQ: MRSN) was upgraded by analysts at BidaskClub from a "buy" rating to a "strong-buy" rating. -12.8%
3/12 Mersana Therapeutics Inc (NASDAQ: MRSN) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -10.7%
8/10 Mersana Therapeutics, Inc. (MRSN) CEO Anna Protopapas on Q2 2019 Results - Earnings Call Transcript [Seeking Alpha] -9.3%
4/9 Form 424B5 Mersana Therapeutics, -9.1%
4/29 Mersana Therapeutics to Host Conference Call Announcing First Quarter 2020 Financial Results and Business Updates -8.9%
4/20 Form DEF 14A Mersana Therapeutics, For: Jun 12 -8.8%
6/1 Mersana Presents Interim Phase 1 Data for XMT-1536 at the 2019 American Society of Clinical Oncology Annual Meeting -8.1%
6/12 Form 8-K Mersana Therapeutics, For: Jun 07 -7.8%
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.
Click Here To Register For The Live Online Workshop
In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

20715 N Pima Rd #F108
Scottsdale, AZ 85255
Email: info@newsquantified.com
Copyright Ⓒ News Quanitifed LLC. 1.1.3